Jacobi Capital Management’s West Pharmaceutical WST Stock Holding History

Jacobi Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$469K	Sell	1,265 -2	-0.2%	-$706	0.02%	456
2026 Q2	$455K	Sell	1,267 -34	-3%	-$10.4K	0.02%	472
2026 Q1	$326K	Sell	1,301 -15	-1%	-$3.73K	0.02%	521
2025 Q4	$362K	Sell	1,316 -29	-2%	-$7.93K	0.02%	484
2025 Q3	$353K	Buy	1,345 +11	+0.8%	+$2.67K	0.02%	469
2025 Q2	$292K	Buy	+1,334	New	+$285K	0.02%	500
2021 Q4	–	Sell	-393	Closed	-$167K	–	1343
2021 Q3	$167K	Buy	393 +364	+1,255%	+$153K	0.02%	430
2021 Q2	$10K	Buy	29 +7	+32%	+$2.31K	﹤0.01%	1041
2021 Q1	$6K	Buy	+22	New	+$6.3K	﹤0.01%	1092

Other funds holding WST

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Jacobi Capital Management's WST Position: Q3 2026 in Review

Jacobi Capital Management reduced its West Pharmaceutical (WST) stake by 0.16% in Q3 2026, selling an estimated $706 and leaving 1,265 shares worth $469K. The position accounts for 0.02% of the portfolio, ranked #456.

Jacobi Capital Management first reported a position in WST in Q1 2021 and has held it in 9 quarters since. 515 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Jacobi Capital Management held 1,265 shares of West Pharmaceutical worth $469K as of Q3 2026.
Jacobi Capital Management sold 2 West Pharmaceutical shares in Q3 2026, an estimated $706.
West Pharmaceutical made up 0.02% of Jacobi Capital Management's portfolio in Q3 2026, its #456 holding.
Jacobi Capital Management first reported a position in West Pharmaceutical in Q1 2021 and has held it in 9 quarters since.
515 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Jacobi Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.